Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$9,491,090
+$2,651,681 QoQ
Shares Held
7,913
+6.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.54%
of 13F equity value
Holder Rank
#1,294
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026King Wealth Management Group holds $17,091,631 across 9 Drug Manufacturers - General names. LLY ranks #1 (55.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
7,913 | $9,491,090 | |
| 2 | JNJ |
Johnson & Johnson
|
15,202 | $3,860,851 | |
| 3 | MRK |
Merck & Co., Inc.
|
7,948 | $1,021,318 | |
| 4 | ABBV |
AbbVie Inc.
|
2,709 | $681,692 | |
| 5 | NVS |
Novartis AG
|
3,251 | $509,496 | |
| 6 | PFE |
Pfizer Inc
|
19,427 | $467,802 | |
| 7 | AMGN |
Amgen Inc
|
1,179 | $426,939 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,843 | $394,293 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,491,090 | 7,913 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $6,839,409 | 7,436 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $8,069,772 | 7,509 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $10,446,233 | 13,691 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $12,891,867 | 16,538 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $20,951,684 | 25,368 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $20,164,640 | 26,120 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $22,573,751 | 25,480 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $23,017,475 | 25,423 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $19,916,553 | 25,601 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $14,771,192 | 25,340 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $9,783,285 | 18,214 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $10,043,675 | 21,416 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $7,637,317 | 22,239 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $6,774,259 | 18,517 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,926,358 | 18,328 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $5,083,277 | 15,678 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,044,681 | 7,140 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,369,884 | 12,200 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,585,911 | 11,192 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,577,968 | 11,232 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,098,362 | 11,232 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,898,099 | 11,242 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,288,070 | 8,702 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $936,154 | 5,702 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $374,821 | 2,702 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||